Adverse drug reactions: finding the needle in the haystackBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7107.500 (Published 30 August 1997) Cite this as: BMJ 1997;315:500
Pharmacovigilance is improving: now we need to ensure that patients benefit
- I Ralph Edwards, Directora
- a Uppsala Monitoring Centre, Stora Torget 3, S-75320 Uppsala, Sweden
Patients need to be sure that the medicines they take are as safe and effective as possible. Concerns over a product's safe use must be discovered, evaluated, and acted on, and the results made available for patient care as expeditiously as possible. In this process spontaneous reports of adverse reactions play an important part, but the problem they present is that of finding needles—true adverse reactions—in large haystacks of suspicions.
There is no substitute for spontaneous adverse drug reaction reports for providing early signals of problems with drugs. The article in this week's issue by Lee et al shows that reporting by pharmacists can make a difference to the number of meaningful reports from hospitals (p 519).1 Britain thus joins 36 other countries in the World Health Organisation's programme on international drug monitoring that accept reports from pharmacists. Britain …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial